181 related articles for article (PubMed ID: 11364914)
21. Moving forward: a treatment overview from the 12th World AIDS Conference.
Agosto M
Newsline People AIDS Coalit N Y; 1998 Sep; ():6-11. PubMed ID: 11367497
[TBL] [Abstract][Full Text] [Related]
22. Treatment of the naive patient.
Bartlett JG
Hopkins HIV Rep; 1999 Mar; 11(2):1, 10-1. PubMed ID: 11366244
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.
Ait-Khaled M; Rakik A; Griffin P; Stone C; Richards N; Thomas D; Falloon J; Tisdale M;
Antivir Ther; 2003 Apr; 8(2):111-20. PubMed ID: 12741623
[TBL] [Abstract][Full Text] [Related]
24. A new HAART on the horizon says the proof is in the potency.
AIDS Alert; 1999 Apr; 14(4):37-9. PubMed ID: 11366218
[TBL] [Abstract][Full Text] [Related]
25. A new approach to initial antiretroviral therapy: protease-sparing combination regimens.
Hanna L
BETA; 1998 Oct; ():9-13. PubMed ID: 11365999
[TBL] [Abstract][Full Text] [Related]
26. Antiretroviral update from the Interscience Conference on Antimicrobial Agents and Chemotherapy.
Newsline People AIDS Coalit N Y; 1998 Dec; ():16-8. PubMed ID: 11367083
[TBL] [Abstract][Full Text] [Related]
27. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Albrecht MA; Bosch RJ; Hammer SM; Liou SH; Kessler H; Para MF; Eron J; Valdez H; Dehlinger M; Katzenstein DA;
N Engl J Med; 2001 Aug; 345(6):398-407. PubMed ID: 11496850
[TBL] [Abstract][Full Text] [Related]
28. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
30. The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load.
Bickel M; Rickerts V; Stephan C; Jacobi V; Rottmann C; Dauer B; Carlebach A; Thalhammer A; Miller V; Staszweski S
HIV Med; 2005 May; 6(3):179-84. PubMed ID: 15876284
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral therapy for previously treated patients.
Montaner JS; Mellors JW
N Engl J Med; 2001 Aug; 345(6):452-5. PubMed ID: 11496858
[No Abstract] [Full Text] [Related]
32. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
33. DMP 266 trials recruiting, many cities -- protease inhibitor naive.
James JS
AIDS Treat News; 1997 Sep; (No 278):5-6. PubMed ID: 11364623
[TBL] [Abstract][Full Text] [Related]
34. CRIA clinical trials.
Newsline People AIDS Coalit N Y; 1998 Sep; ():59. PubMed ID: 11367496
[TBL] [Abstract][Full Text] [Related]
35. Trials for protease failure.
Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
[TBL] [Abstract][Full Text] [Related]
36. Antivirals update.
Proj Inf Perspect; 1998 Dec; (26):8-10. PubMed ID: 11366501
[TBL] [Abstract][Full Text] [Related]
37. Comparative biological and clinical outcomes after a switch from a virologically unsuccessful first protease inhibitor-containing antiretroviral combination to a 3-drug regimen containing efavirenz, nevirapine, or abacavir.
Abgrall S; Yeni PG; Bouchaud O; Costagliola D;
Clin Infect Dis; 2007 Jan; 44(1):120-7. PubMed ID: 17143827
[TBL] [Abstract][Full Text] [Related]
38. New expanded access drugs for use in combination therapy.
Notes Undergr; 1998; (No 37):suppl 1-2. PubMed ID: 11365823
[TBL] [Abstract][Full Text] [Related]
39. Preparing for the future.
Cox S
Posit Aware; 1997; 8(2):10-1. PubMed ID: 11364448
[TBL] [Abstract][Full Text] [Related]
40. New treatment options.
Fornataro K; Jefferys R
Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
